XML 50 R36.htm IDEA: XBRL DOCUMENT v3.21.1
SEGMENT INFORMATION
12 Months Ended
Dec. 31, 2020
SEGMENT INFORMATION  
SEGMENT INFORMATION

29— SEGMENT INFORMATION

We recently implemented organizational changes in our structure and realigned our activity into three divisions: HIFU, ESWL (including lithotripsy activities) and Distribution to better reflect how we view our businesses and how we measure our progress. Through these three divisions, we develop, produce, market and distribute minimally invasive medical devices, mainly for urological diseases. HIFU division includes sales of Focal One, Ablatherm and related consumables and services, ESWL division includes revenues generated by the existing Sonolith range of lithotripters and, Distribution division includes the sale of complimentary products such as lasers, micro-ultrasound systems and other products from third parties.

The organization of our activities into three divisions better clarified our vision and enhanced our financial reporting of our three businesses HIFU, ESWL and Distribution. This new structure also allows for an improved measurement of our business progress.

The business in which the Company operates is the development, production and distribution of minimally invasive medical devices, primarily for the treatment of urological diseases. Substantially all revenues result from the sale of medical devices and their related license and royalty payments from third parties. The segments derive their revenues from this activity.

The following tables set forth the key Statement of income (loss) figures, by segment for fiscal years 2020, 2019 and 2018 and the key balance sheet figures, by segment, for fiscal years 2020, 2019 and 2018. Segment operating profit or loss and segment assets are determined in accordance with the same policies as those described in the summary of significant accounting policies and they are reviewed by the CODM, who is the CEO. Interest income and expense, current and deferred income taxes are not allocated to individual segments. A reconciliation of segment operating profit or loss to consolidated net loss is as follows:

    

2020

    

2019

    

2018

Segment operating income (loss)

 

269

 

2,201

 

(1,315)

Financial income (expense), net

 

(98)

 

(146)

 

797

Foreign Currency exchange (losses) gains, net

 

(1,359)

 

136

 

538

Income tax (expense) credit

 

(516)

 

(679)

 

(358)

Consolidated net profit (loss)

 

(1,704)

 

1,512

 

(338)

A summary of the Company’s operations by segment is presented below for years ending December 31, 2020, 2019 and 2018:

    

HIFU

    

ESWL

    

DISTRIB

    

Reconciling

    

Total

2020

Division

Division

Division

Items

consolidated

Sales of goods

 

6,000

 

6,248

 

15,274

 

27,523

Sales of RPPs & leases

 

3,594

 

927

 

224

 

4,745

Sales of spare parts and services

 

1,831

 

5,707

 

1,844

 

9,382

Total sales

 

11,425

 

12,882

 

17,342

 

41,649

External other revenues

 

12

 

 

 

12

Total revenues

 

11,438

 

12,882

 

17,342

 

41,662

Total COS

 

(5,144)

 

(7,232)

 

(10,906)

 

(23,283)

Gross profit

 

6,293

 

5,649

 

6,436

 

18,379

R&D expenses

 

(2,583)

 

(1,555)

 

(358)

 

(4,496)

Selling and marketing expenses

 

(3,151)

 

(2,052)

 

(4,076)

 

(9,279)

G&A expenses

 

(1,005)

 

(964)

 

(900)

 

(1,465)

 

(4,335)

Total expenses

 

(6,738)

 

(4,572)

 

(5,335)

 

(1,465)

 

(18,110)

Operating income (loss) from operations

 

(445)

 

1,078

 

1,102

 

(1,465)

 

269

Total Assets

 

16,279

 

15,567

 

20,795

 

2,551

 

55,193

Capital expenditures

 

1,144

 

309

 

557

 

 

2,011

Non-current assets

 

3,706

 

2,466

 

3,628

 

 

9,801

Goodwill

 

645

 

496

 

1,271

 

 

2,412

    

HIFU

    

ESWL

    

DISTRIB

    

Reconciling

    

Total

2019

Division

Division

Division

Items

consolidated

Sales of goods

 

8,311

 

6,715

 

15,084

 

 

30,111

Sales of RPPs & leases

 

4,162

 

1,426

 

158

 

 

5,747

Sales of spare parts and services

 

1,618

 

6,048

 

1,335

 

 

9,001

Total sales

 

14,092

 

14,190

 

16,578

 

 

44,859

External other revenues

 

52

 

 

 

 

52

Total revenues

 

14,144

 

14,190

 

16,578

 

 

44,912

Total COS

 

(6,152)

 

(7,816)

 

(9,941)

 

 

(23,909)

Gross profit

 

7,991

 

6,374

 

6,637

 

 

21,002

R&D expenses

 

(1,962)

 

(1,394)

 

(372)

 

 

(3,728)

Selling and marketing expenses

 

(4,402)

 

(2,441)

 

(4,008)

 

 

(10,850)

G&A expenses

 

(1,168)

 

(904)

 

(854)

 

 

(4,224)

Total expenses

 

(7,533)

 

(4,738)

 

(5,233)

 

 

(18,802)

Operating income (loss) from operations

 

459

 

1,635

 

1,404

 

 

2,201

Total Assets

 

16,665

 

15,892

 

16,500

 

4,012

 

53,068

Capital expenditures

 

915

 

298

 

319

 

 

1,532

Non-current assets

 

4,096

 

4,448

 

2,427

 

 

10,971

Goodwill

 

645

 

450

 

1,317

 

 

2,412

    

HIFU

    

ESWL

    

DISTRIB

    

Reconciling

    

Total

2018

Division

Division

Division

Items

consolidated

Sales of goods

 

5,494

 

7,069

 

12,505

 

 

25,070

Sales of RPPs & leases

 

3,750

 

1,254

 

82

 

 

5,086

Sales of spare parts and services

 

1,780

 

6,157

 

1,070

 

 

9,007

Total sales

 

11,025

 

14,480

 

13,657

 

 

39,163

External other revenues

 

19

 

 

 

 

19

Total revenues

 

11,044

 

14,480

 

13,657

 

 

39,183

Total COS

 

(5,312)

 

(8,178)

 

(8,775)

 

 

(22,266)

Gross profit

 

5,732

 

6,302

 

4,882

 

 

16,917

R&D expenses

 

(2,394)

 

(1,410)

 

(285)

 

 

(4,088)

Selling and marketing expenses

 

(4,628)

 

(2,357)

 

(3,566)

 

 

(10,551)

G&A expenses

 

(1,036)

 

(731)

 

(580)

 

(1,247)

 

(3,593)

Total expenses

 

(8,057)

 

(4,498)

 

(4,431)

 

(1,247)

 

(18,232)

Operating income (loss) from operations

 

(2,325)

 

1,804

 

451

 

(1,247)

 

(1,316)

Total Assets

 

13,648

 

16,700

 

13,149

 

5,243

 

48,740

Capital expenditures

 

1,154

 

451

 

324

 

 

1,928

Non-current assets

 

2,855

 

3,697

 

1,462

 

 

8,013

Goodwill

 

645

 

403

 

1,364

 

 

2,412